Učitavanje...
Antibody–drug conjugates for cancer therapy
Antibody–drug conjugates are monoclonal antibodies conjugated to cytotoxic agents. They use antibodies that are specific to tumour cell-surface proteins and, thus, have tumour specificity and potency not achievable with traditional drugs. Design of effective antibody–drug conjugates for cancer thera...
Spremljeno u:
| Izdano u: | Lancet Oncol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6601617/ https://ncbi.nlm.nih.gov/pubmed/27299281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)30030-4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|